…
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Ebit | 162.86M | - | 21.37M | 15.18M |
| Other operating expenses | - | - | - | 0.67M |
| Income tax expense | 20.20M | -20.44M | 4.05M | 2.65M |
| Net income applicable to common shares | 187.97M | 86.25M | 15.61M | 12.60M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Other current liab | - | 93.83M | 19.11M | 26.99M |
| Common stock | 2.54M | 2.54M | 1.73M | 1.68M |
| Retained earnings | 273.79M | 85.82M | -0.43M | -16.04M |
| Other liab | - | 148.61M | 11.63M | 12.71M |
| Other assets | 26.52M | 29.56M | 6.93M | 7.18M |
| Total current liabilities | 305.91M | 232.38M | 31.28M | 39.58M |
| Other stockholder equity | 581.13M | 117.73M | 0.14M | -0.28M |
| Property plant equipment | 51.36M | 38.39M | 8.55M | 9.07M |
| Total current assets | 826.37M | 616.91M | 133.39M | 112.77M |
| Net tangible assets | 491.14M | 291.81M | 103.65M | 74.49M |
| Net receivables | - | 179.79M | 32.07M | 32.47M |
| Inventory | 134.88M | 113.11M | 12.46M | 7.19M |
| Accounts payable | - | 34.37M | 2.30M | 2.37M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Change to liabilities | - | - | 0.00M | 0.00M | 0.00M |
| Total cashflows from investing activities | - | - | -34.55M | -2732.61M | -8.69M |
| Net borrowings | - | - | 17.09M | -31.72M | -5.14M |
| Total cash from financing activities | - | - | 17.09M | 2922.46M | 4.21M |
| Change to operating activities | - | - | 26.87M | 31.43M | -2.43M |
| Net income | 131.65M | 234.00M | 187.97M | 86.25M | 15.61M |
| Change in cash | - | - | 117.05M | 229.52M | 17.94M |
| Total cash from operating activities | - | - | 129.49M | 39.08M | 23.23M |
| Depreciation | - | - | - | 23.90M | 10.25M |
| Change to inventory | - | - | -21.72M | 6.46M | -5.27M |
| Change to account receivables | - | - | -70.76M | -84.57M | 1.86M |
| Other cashflows from financing activities | - | - | - | -84.87M | 1.49M |
| Change to netincome | - | - | -44.46M | -33.99M | -3.52M |
| Capital expenditures | 0.00M | 0.00M | 9.35M | 3.87M | 0.40M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0AAU Surgical Science Sweden AB |
0.55 0.94% |
59.25 | 0.14 | - | - | - |
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.
| Name | Title | Year Born |
|---|---|---|
| Mr. Gisli Hennermark | Chief Exec. Officer | 1972 |
| Mr. Anders Larsson | Co-Founder & CTO | 1973 |
| Ms. Anna Ahlberg | Chief Financial Officer | 1970 |
| Mr. Boaz Tal ), Adv. (CPA, C.P.A. | Chief Operating Officer | 1968 |
| Mr. Martin Jansson | Head of Global Sales | 1971 |
| Ms. Inbal Mazor-Badichi | VP of Products & Marketing | 1969 |
| Mr. Doron Zilberman | VP for International Sales | 1962 |
| Mr. Daniel Evestedt | Head of Devel. | 1977 |
| Mr. Jeffrey Berkley Ph.D. | Chief Innovation Officer | 1969 |
| Mr. Ran Bronstein | Pres of R&D | 1964 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.